Larvol Delta - CNS-Pharmaceuticals-Receives-Approval-from-Competent-Authority-and-Central-Ethics-Committee-in-Italy-for-Potentially-Pivotal-Global-Trial-Evaluating-Berubicin-for-the-Treatment-of-GBM

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.biospace.com/article/releases/cns-pharmaceuticals-receives-approval-from-competent-authority-and-central-ethics-committee-in-italy-for-potentially-pivotal-global-trial-evaluating-berubicin-for-the-treatment-of-gbm/

Apr 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next